Gabelli Securities Increased Syngenta Ag Adr Sponsored (SYT) Holding By $2.01 Million; Shorts at Cti Biopharma (CTIC) Raised By 3.63%

May 29, 2017 - By Ellis Scott

Cti Biopharma Corporation (NASDAQ:CTIC) had an increase of 3.63% in short interest. CTIC’s SI was 1.35 million shares in May as released by FINRA. Its up 3.63% from 1.30M shares previously. With 79,900 avg volume, 17 days are for Cti Biopharma Corporation (NASDAQ:CTIC)’s short sellers to cover CTIC’s short positions. The SI to Cti Biopharma Corporation’s float is 6.3%. The stock increased 0.24% or $0.01 on May 26, reaching $4.18. About 14,365 shares traded. CTI BioPharma Corp (NASDAQ:CTIC) has declined 4.09% since May 29, 2016 and is downtrending. It has underperformed by 20.79% the S&P500.

Gabelli Securities Inc increased Syngenta Ag Adr Sponsored (SYT) stake by 9.99% reported in 2016Q4 SEC filing. Gabelli Securities Inc acquired 25,425 shares as Syngenta Ag Adr Sponsored (SYT)’s stock rose 8.07%. The Gabelli Securities Inc holds 279,985 shares with $22.13M value, up from 254,560 last quarter. Syngenta Ag Adr Sponsored now has $40.84 billion valuation. The stock decreased 1.76% or $1.63 on May 26, reaching $91.09. About 419,361 shares traded. Syngenta AG (ADR) (NYSE:SYT) has risen 15.69% since May 29, 2016 and is uptrending. It has underperformed by 1.01% the S&P500.

CTI BioPharma Corp. is a biopharmaceutical firm focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers to patients and healthcare providers. The company has market cap of $118.22 million. The Firm is primarily focused on commercializing PIXUVRI in select countries in the European Union, for multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (NHL). It currently has negative earnings. It is also engaged in evaluating pacritinib for the treatment of adult patients with myelofibrosis.

Investors sentiment increased to 0.62 in 2016 Q4. Its up 0.02, from 0.6 in 2016Q3. It increased, as 12 investors sold CTI BioPharma Corp shares while 17 reduced holdings. 7 funds opened positions while 11 raised stakes. 65.67 million shares or 7.55% less from 71.03 million shares in 2016Q3 were reported. Blackrock Institutional Trust Na holds 3.46M shares. Guggenheim Capital Ltd Liability Co accumulated 63,017 shares or 0% of the stock. D E Shaw Co invested in 0% or 23,260 shares. Bokf Na invested 0% in CTI BioPharma Corp (NASDAQ:CTIC). California Employees Retirement has invested 0% in CTI BioPharma Corp (NASDAQ:CTIC). Jacobs Levy Equity Management holds 322,389 shares. Live Your Vision Limited Liability Corporation owns 66 shares. Washington Trust reported 314,000 shares. Aqr Capital Ltd Limited Liability Company, Connecticut-based fund reported 80,700 shares. Blackrock Fund Advisors stated it has 52,768 shares. Modera Wealth Mgmt holds 25,000 shares or 0% of its portfolio. 450,504 are owned by Millennium Mgmt Ltd Company. Kcg Hldgs holds 108,011 shares. Susquehanna Interest Grp Ltd Liability Partnership, a Pennsylvania-based fund reported 118,181 shares. Northern Tru, a Illinois-based fund reported 373,181 shares.

Gabelli Securities Inc decreased Loral Space & Communicatns Ico (NASDAQ:LORL) stake by 11,607 shares to 81,065 valued at $3.33 million in 2016Q4. It also reduced Alere Inc (NYSE:ALR) stake by 54,343 shares and now owns 469,239 shares. Intersil Hldg Corp Cl A (NASDAQ:ISIL) was reduced too.